PROTEINFORMULIERUNGEN

Patent europeic · EP3160511 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3160511
Numer da la dumonda
EP15738505
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-06-2015
Publitgà
03-05-2017
Concedì
26-07-2023
La protecziun finescha il pli tard
14-06-2035
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61K 38/18 (2006.01)
A61K 47/20 (2006.01)
A61P 7/06 (2006.01)
A61P 37/02 (2006.01)
A61K 47/26 (2006.01)
A61K 9/19 (2006.01)
A61K 47/18 (2017.01)
Prioritad
US 201462017560 P 26.06.2014
Dumonda PCT
PCT/US2015/035884 15.06.2015
Publicaziun PCT
WO2015/200027 30.12.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 05-06-2024

    Midada

    Published in Swissreg on 05.06.2024

  5. 26-07-2023

    Concedì

    Published in Swissreg on 26.07.2023

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventur

MCAULEY, Arnold J.

Moorpark, California 93021, US

PARK, Sungae

Thousand Oaks, California 91320, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.